Home › Trial NCT00708903
Study to Examine the Effect of HKI-272 on Rhythms of the Heart (Cardiac Repolarization)
- Trial IDNCT00708903
- StatusCompleted
- PhasePhase 1
- Study typeInterventional
- SponsorPuma Biotechnology, Inc.
- Enrollment60
- Start date2008-05
- ConditionsBreast Cancer
Enriched analysis
Parsed endpoints, structured eligibility, drug class and a plain-English summary — shown to verified visitors to prevent automated scraping.
Trial data from ClinicalTrials.gov (U.S. public domain) and ISRCTN (CC BY 4.0), used with attribution. TrialLens is an independent index, not affiliated with or endorsed by ClinicalTrials.gov, the NIH, or any trial sponsor. For research only — not medical advice.